{"id":408677,"date":"2021-01-05T09:33:26","date_gmt":"2021-01-05T14:33:26","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=408677"},"modified":"2021-01-05T09:33:26","modified_gmt":"2021-01-05T14:33:26","slug":"therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/","title":{"rendered":"Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity"},"content":{"rendered":"
\n

Company Continues Elucidation of Immunological Mechanisms of QuadraMune\u2122 Nutraceutical Currently in Clinical Trials for COVID-19 Prevention<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n OCEANSIDE, Calif.<\/span>, Jan.\u00a05, 2021 \/PRNewswire\/ — Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data from its ongoing investigations into the immunological mechanisms by which QuadraMune\u2122 functions as a potential antiviral nutraceutical.\u00a0 <\/p>\n

In mice receiving QuadraMune\u2122 for a period of two weeks, a significantly increased cytotoxic T cell response was seen after immunization with proteins that resemble virally associated proteins.\u00a0 T cytotoxic cells are a component of the immune system which selectively kills virally infected cells.\u00a0 Successful immunity to viruses is dependent on T cytotoxic cell activity. <\/p>\n

“Last week we reported data that QuadraMune\u2122 increases Th1 cell activity, which orchestrates antiviral immunity.\u00a0 This week we demonstrated that QuadraMune\u2122 increases T cytotoxic cell activity.\u00a0 The T cytotoxic cell being the actual effector cells of adaptive antiviral immunity,” said Dr. James Veltmeyer<\/span>, Chief Medical Officer of the Company. “The fact that we are using natural ingredients to boost up various components of the immune system that are needed to fight viruses makes us confident in the outcome of our ongoing COVID-19 prevention clinical trial.”<\/p>\n

“While many of our colleagues are scrambling to utilize synthetic immune stimulants, whose long-term consequences are not well understood, we are excited to be leveraging natural ingredients such as nigella sativa, whose therapeutic effects have been well described in the literature for thousands of years,” said Famela Ramos<\/span>, Vice President of Business Development. “To my knowledge we are one of the only companies that is actually leveraging modern day immunological sciences to optimize herbal compositions and remedies.”<\/p>\n

“Through understanding the cellular and molecular mechanisms by which QuadraMune\u2122 works, we are confident in the rapid acceptance of our nutraceutical by the medical community as a natural approach to boosting the proper immunity needed to fight off viruses,” stated Timothy Dixon<\/span>, President and CEO of the Company.\u00a0 “Combined with the known effects of QuadraMune ingredients in suppressing the NLRP3 inflammasome pathway, we believe that our scientists have developed a ‘first in class’ nutraceutical to potentially address both immune deficiency and hyperinflammation associated with COVID-19.”<\/p>\n

\n About Therapeutic Solutions International, Inc.
<\/b>Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company’s corporate website is www.therapeuticsolutionsint.com<\/a>, and our public forum is https:\/\/board.therapeuticsolutionsint.com\/<\/a>. <\/p>\n

CONTACT:\u00a0 ir@tsoimail.com<\/a><\/p>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity-301201036.html<\/a><\/p>\n

SOURCE Therapeutic Solutions International<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Company Continues Elucidation of Immunological Mechanisms of QuadraMune\u2122 Nutraceutical Currently in Clinical Trials for COVID-19 Prevention PR Newswire OCEANSIDE, Calif., Jan.\u00a05, 2021 \/PRNewswire\/ — Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data from its ongoing investigations into the immunological mechanisms by which QuadraMune\u2122 functions as a potential antiviral nutraceutical.\u00a0 In mice receiving QuadraMune\u2122 for a period of two weeks, a significantly increased cytotoxic T cell response was seen after immunization with proteins that resemble virally associated proteins.\u00a0 T cytotoxic cells are a component of the immune system which selectively kills virally infected cells.\u00a0 Successful immunity to viruses is dependent on T cytotoxic cell activity. “Last week we reported data that QuadraMune\u2122 increases Th1 cell activity, which orchestrates … <\/p>\n

Continue reading “Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-408677","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTherapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company Continues Elucidation of Immunological Mechanisms of QuadraMune\u2122 Nutraceutical Currently in Clinical Trials for COVID-19 Prevention PR Newswire OCEANSIDE, Calif., Jan.\u00a05, 2021 \/PRNewswire\/ — Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data from its ongoing investigations into the immunological mechanisms by which QuadraMune\u2122 functions as a potential antiviral nutraceutical.\u00a0 In mice receiving QuadraMune\u2122 for a period of two weeks, a significantly increased cytotoxic T cell response was seen after immunization with proteins that resemble virally associated proteins.\u00a0 T cytotoxic cells are a component of the immune system which selectively kills virally infected cells.\u00a0 Successful immunity to viruses is dependent on T cytotoxic cell activity. “Last week we reported data that QuadraMune\u2122 increases Th1 cell activity, which orchestrates … Continue reading "Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-05T14:33:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=AQ37549&sd=2021-01-05\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity\",\"datePublished\":\"2021-01-05T14:33:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/\"},\"wordCount\":424,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=AQ37549&sd=2021-01-05\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/\",\"name\":\"Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=AQ37549&sd=2021-01-05\",\"datePublished\":\"2021-01-05T14:33:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=AQ37549&sd=2021-01-05\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=AQ37549&sd=2021-01-05\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/","og_locale":"en_US","og_type":"article","og_title":"Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity - Market Newsdesk","og_description":"Company Continues Elucidation of Immunological Mechanisms of QuadraMune\u2122 Nutraceutical Currently in Clinical Trials for COVID-19 Prevention PR Newswire OCEANSIDE, Calif., Jan.\u00a05, 2021 \/PRNewswire\/ — Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data from its ongoing investigations into the immunological mechanisms by which QuadraMune\u2122 functions as a potential antiviral nutraceutical.\u00a0 In mice receiving QuadraMune\u2122 for a period of two weeks, a significantly increased cytotoxic T cell response was seen after immunization with proteins that resemble virally associated proteins.\u00a0 T cytotoxic cells are a component of the immune system which selectively kills virally infected cells.\u00a0 Successful immunity to viruses is dependent on T cytotoxic cell activity. “Last week we reported data that QuadraMune\u2122 increases Th1 cell activity, which orchestrates … Continue reading \"Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-05T14:33:26+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=AQ37549&sd=2021-01-05","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity","datePublished":"2021-01-05T14:33:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/"},"wordCount":424,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=AQ37549&sd=2021-01-05","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/","name":"Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=AQ37549&sd=2021-01-05","datePublished":"2021-01-05T14:33:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=AQ37549&sd=2021-01-05","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=AQ37549&sd=2021-01-05"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Therapeutic Solutions International Reports QuadraMune\u2122 Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408677","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=408677"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408677\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=408677"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=408677"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=408677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}